News & Analysis on Clinical Trial Services & Contract Research And Development
US officials' new take on import rules may mean APIs destined for trials will only be allowed into the country if they are listed in an effective IND application, according to Clinipace QA chief Nikolas Burlew.
update
Novasep has discovered that the drug manufacturing regent Togni II is highly explosive and as inflammable as gunpowder.
Eisai has tasked a new exec with making trials more likely to succeed just a few months after its candidate ovarian cancer blockbuster failed at Phase III.
French biotech company ANGANY Genetics says its new platform can provide pharma companies low cost and high quality recombinant allergens for drug testing purposes.
Update
Covance says anticipated future demand across the Asia Pacific region drove the latest expansion of its services in Singapore.
The expansion of CoreRx’s Clearwater, Florida facility will allow for hormone development, clinical trial and commercial manufacturing, and create about 25 new jobs.
The US FDA is giving generic drug facilities one month to self-identify for FY 2014 so that the agency can calculate how much to charge the companies in user fees for application reviews and inspections.